Drug intelligence / Profile preview

Wenshen Yiqi

Development stage
Unknown
Lead developer
The Second Affiliated Hospital of Zhejiang Chinese Medical University
Modality
Small Molecules
Administration
Oral
01

Overview

Wenshen Yiqi is a traditional Chinese medicine (TCM) compound prescription commonly formulated as granules or "keli" (granulated extract). It is primarily used for the treatment of chronic obstructive pulmonary disease (COPD), especially in patients diagnosed with lung and kidney qi deficiency according to TCM principles. The formulation contains multiple herbal ingredients whose precise composition may vary by manufacturer but typically aims to tonify the kidney and supplement qi. Mechanistically, preclinical studies suggest that it alleviates airway inflammation and remodeling by modulating molecular pathways such as the long noncoding RNA-XIST/microRNA-200c-3p axis and the miR-155/FoxO3a axis. These actions result in reduced proliferation and migration of human airway smooth muscle cells exposed to cigarette smoke extract, potentially through upregulation of cell cycle inhibitors (p21, p27) and FoxO3a while downregulating proliferative markers (PCNA, Ki67)[1][2][3][4][10]. Clinical trials are ongoing for COPD; other experimental models have explored its effects on severe pneumonia[7].

Brand names
Wenshen Yiqi GranuleWenshen Yiqi Keli
Other names
Wenshen Yiqi medicine
02

Targets

FOXO3 (Forkhead box protein O3)

Beyond the preview

Go deeper on Wenshen Yiqi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wenshen Yiqi.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call